Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-3,105
Closed -$212K 507
2019
Q4
$212K Buy
+3,105
New +$195K 0.01% 1140
2018
Q4
Sell
-4,400
Closed -$1.07M 1480
2018
Q3
$1.07M Buy
+4,400
New +$1.02M 0.05% 552
2018
Q2
Sell
-4,900
Closed -$601K 1586
2018
Q1
$601K Buy
+4,900
New +$598K 0.02% 874
2016
Q3
Sell
-6,715
Closed -$336K 880
2016
Q2
$336K Sell
6,715
-8,700
-56% -$415K 0.02% 935
2016
Q1
$693K Buy
15,415
+2,600
+20% +$92.6K 0.03% 736
2015
Q4
$513K Sell
12,815
-16,993
-57% -$718K 0.02% 856
2015
Q3
$1.45M Buy
+29,808
New +$1.42M 0.05% 502
2015
Q2
Sell
-21,321
Closed -$682K 1575
2015
Q1
$682K Buy
+21,321
New +$688K 0.02% 802

Other funds holding INGN

A.R.T. Advisors's INGN Position: Q1 2020 in Review

A.R.T. Advisors sold out of Inogen (INGN) in Q1 2020, closing a stake of 3,105 shares — an estimated $212K sold.

A.R.T. Advisors first reported a position in INGN in Q1 2015 and held it in 8 quarters. The position peaked at $1.45M in Q3 2015. 179 funds tracked by Wall St. Rank hold INGN as of Q1 2020.

  • A.R.T. Advisors reported no remaining Inogen position as of Q1 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 3,105 Inogen shares in Q1 2020, an estimated $212K.
  • A.R.T. Advisors first reported a position in Inogen in Q1 2015 and held it in 8 quarters.
  • A.R.T. Advisors's Inogen position peaked at $1.45M in Q3 2015.
  • 179 funds tracked by Wall St. Rank held Inogen as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.